Your browser doesn't support javascript.
loading
Low miR200c expression in tumor budding of invasive front predicts worse survival in patients with localized colon cancer and is related to PD-L1 overexpression.
Martinez-Ciarpaglini, Carolina; Oltra, Sara; Roselló, Susana; Roda, Desamparados; Mongort, Cristina; Carrasco, Francisca; Gonzalez, José; Santonja, Francisco; Tarazona, Noelia; Huerta, Marisol; Espí, Alejandro; Ribas, Gloria; Ferrández, Antonio; Navarro, Samuel; Cervantes, Andres.
Afiliación
  • Martinez-Ciarpaglini C; Department of Pathology, Biomedical Research Institute INCLIVA, Valencia, Spain. carolmartinez@incliva.es.
  • Oltra S; Department of Medical Oncology, Biomedical Research Institute INCLIVA, CiberOnc, University of Valencia, Valencia, Spain.
  • Roselló S; Department of Medical Oncology, Biomedical Research Institute INCLIVA, CiberOnc, University of Valencia, Valencia, Spain.
  • Roda D; Department of Medical Oncology, Biomedical Research Institute INCLIVA, CiberOnc, University of Valencia, Valencia, Spain.
  • Mongort C; Department of Medical Oncology, Biomedical Research Institute INCLIVA, CiberOnc, University of Valencia, Valencia, Spain.
  • Carrasco F; Department of Medical Oncology, Biomedical Research Institute INCLIVA, CiberOnc, University of Valencia, Valencia, Spain.
  • Gonzalez J; Department of Pathology, Biomedical Research Institute INCLIVA, Valencia, Spain.
  • Santonja F; Department of Statistics and Operations Research, University of Valencia, Valencia, Spain.
  • Tarazona N; Department of Medical Oncology, Biomedical Research Institute INCLIVA, CiberOnc, University of Valencia, Valencia, Spain.
  • Huerta M; Department of Medical Oncology, Biomedical Research Institute INCLIVA, CiberOnc, University of Valencia, Valencia, Spain.
  • Espí A; Department of Surgery, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain.
  • Ribas G; Department of Medical Oncology, Biomedical Research Institute INCLIVA, CiberOnc, University of Valencia, Valencia, Spain.
  • Ferrández A; Department of Pathology, Biomedical Research Institute INCLIVA, Valencia, Spain.
  • Navarro S; Department of Pathology, Biomedical Research Institute INCLIVA. CiberOnc, University of Valencia, Valencia, Spain.
  • Cervantes A; Department of Medical Oncology, Biomedical Research Institute INCLIVA, CiberOnc, University of Valencia, Valencia, Spain.
Mod Pathol ; 32(2): 306-313, 2019 02.
Article en En | MEDLINE | ID: mdl-30206410
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias del Colon / MicroARNs / Transición Epitelial-Mesenquimal / Antígeno B7-H1 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Mod Pathol Asunto de la revista: PATOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias del Colon / MicroARNs / Transición Epitelial-Mesenquimal / Antígeno B7-H1 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Mod Pathol Asunto de la revista: PATOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: España